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Abstract
Tributyltin (TBT) and dibutyltin (DBT) are widespread environmental contaminants found in 
food, beverages, and human blood samples. Both of these butyltins (BTs) interfere with the ability 
of human natural killer (NK) cells to lyse target cells and also alter secretion of the pro-
inflammatory cytokine tumor necrosis factor alpha (TNFα) from human immune cells in vitro. 
The capacity of BTs to interfere with secretion of other pro-inflammatory cytokines has not been 
examined. Interferon gamma (IFNγ) is a modulator of adaptive and innate immune responses, 
playing an important role in overall immune competence. This study shows that both TBT and 
DBT alter secretion of IFNγ from human immune cells. Peripheral blood cell preparations that 
were increasingly reconstituted were used to determine if exposures to either TBT or DBT 
affected IFNγ secretion and how the makeup of the cell preparation influenced that effect. IFNγ 
secretion was examined after 24 h, 48 h and 6 day exposures to TBT (200- 2.5 nM) and DBT (5- 
0.05 μM) in highly enriched human NK cells, a monocyte-depleted preparation of PBMCs, and 
monocyte-containing PBMCs. Both BTs altered IFNγ secretion from NK cells at most of the 
conditions tested (either increasing or decreasing secretion). However, there was significant 
variability among donors as to the concentrations and time points that showed changes as well as 
the baseline secretion of IFNγ. The majority of donors showed an increase in IFNγ secretion in 
response to at least one concentration of TBT or DBT at a minimum of one length of exposure.
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INTRODUCTION
The use of butyltins (BTs) in various applications has led to very significant contamination 
of the environment by these compounds (Kimbrough, 1976; Tanabe et al. 1998; Loganathan 
et al., 2000; Roper, 1992; Gipperth, 2009; Takahashi et al., 1999; Kannan et al., 1995; 
Forsyth et al., 1992; 1997; Sadiki et al., 1996). Tributyltin (TBT) has been used as an 
ingredient in antifouling paints as well as an antifungal agent and biocide in textiles, paper 
production, industrial cooling waters, and wood preservation (Kimbrough, 1976; Laughlin 
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and Linden, 1985; Roper, 1992). Its use in antifouling paints has been banned since 2008 but 
it will continue to contaminate the environment for many years due to its chemical stability 
and other uses (Gipperth, 2009). TBT is found in food, especially fish, (Kannan et al., 1995; 
Takahashi et al., 1999) and also in human blood. Blood levels range as high as 261 nM (85 
ng/mL) (Whalen et al., 1999; Kannan et al., 1999). Studies show that the exposure of 
mammals to TBT causes increased incidences of tumors (Wester et al., 1990), decreased NK 
cell function (Ghoneum et al., 1990), thymic atrophy and thymus dependent 
immunosuppression (Snoeij et al., 1987, 1989; Vos et al. 1990). Dibutyltin (DBT) is used as 
a stabilizer in plastics (Roper, 1976) and as an anti-worming agent in some poultry (Epstein 
et al. 1991). DBT is also found in drinking water and other beverages due to leaching from 
PVC plastics used in their production and/or storage (Forsyth et al., 1992, 1997; Sadiki et 
al., 1996). Levels of DBT in human blood are as high as 300 nM (94 ng/mL) (Whalen et al., 
1999; Kannan et al., 1999). Both TBT and DBT decrease lytic function, target-binding 
function, cell-surface protein expression, and cytolytic protein expression in human natural 
killer (NK) cells at levels that are in the range found in human blood (Whalen et al., 1999; 
Dudimah et al., 2007a, b; Whalen et al., 2002; Odman-Ghazi et al., 2003; Thomas et al., 
2004; Catlin et al., 2005). These changes are accompanied by a rapid activation of a portion 
of the signaling pathway(s) that regulates NK lytic function (beginning with protein kinase 
C through mitogen-activated protein kinases (MAPKs) (Aluoch and Whalen, 2005; Aluoch 
et al., 2006; Aluoch et al., 2007; Odman-Ghazi et al., 2010; Abraha et al., 2010). Recently, 
we have shown that exposure to these BTs alters the secretion of the cytokine tumor necrosis 
factor alpha (TNFα) from human immune cells including NK cells (Hurt et al. 2013).
The functions of both innate and adaptive immune cells are regulated by the cytokine 
interferon gamma (IFNγ). It causes increased antigen presentation on macrophages by 
increasing their expression of MHC class I molecules and regulates T cell immune response 
through Th1 cells. It is also involved in the recruitment of innate immune cells to sites of 
infection or tumor (Zaidi and Merlino, 2011). IFNγ is an approximately 17kD protein, which 
is dimerized in its physiologically active form (Billau and Matthys, 2009). It is secreted by T 
cells, NK cells, and to a lesser extent by myeloid lineage cells such as macrophages (Billiau 
and Matthys, 2009; Darwich et al., 2008). IFNγ is a pro-inflammatory cytokine which has 
the ability to cause chronic inflammation, which has been shown to facilitate the 
development of certain cancers such as gastrointestinal cancers (Macarthur et al., 2004). 
Careful regulation of IFNγ is crucial in order to avoid loss of immune competency or the 
increased risks associated with chronic inflammation. IFNγ may behave both in a pro-
tumorigenic as well as in an antitumor manner depending on the specific circumstances. 
Under circumstances where IFNγ increases tumor cell death by macrophages, T cells, and 
NK cells it will prevent cancer development. However, the stimulation of myeloid derived 
suppressor cell development by IFNγ may lead to cancer (Zaidi and Merlino, 2011).
Natural killer (NK) cells are capable of secreting IFNγ (Andoniou et al., 2008; Girart et al., 
2007) and we have found that both TBT and DBT have dramatic effects on the ability of 
human NK cells to destroy tumor cells (Dudimah et el., 2007a, b) as well as their ability to 
secrete the pro-inflammatory cytokine TNFα (Hurt et al., 2013). In addition we showed that 
both BTs interfered with the secretion of TNFα from a preparation of peripheral blood 
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mononuclear cells (PBMCs) that had been depleted of monocytes (Hurt et al., 2013). Thus, 
there is interest in investigating whether either TBT or DBT has the ability to alter immune 
cell secretion of other pro-inflammatory cytokines including IFNγ.
The current study examined the effects of exposures to TBT or DBT on secretion of IFNγ 
from highly purified NK cells, monocyte-depleted PBMCs, and PBMCs. Examination of the 
effects of these compound on IFNγ secretion from increasingly reconstituted systems 
allowed us to determine whether there were differences in the effects of the BTs between the 
purified NK system and the more complex systems of immune cells, thus more closely 
approximating the physiological setting.
MATERIALS AND METHODS
Preparation of NK cells
NK cells were prepared from buffy coats (source leukocytes from healthy adult donors) 
purchased from Key Biologics, LLC (Memphis, TN). Highly purified NK cells were 
prepared using a rosetting procedure. RosetteSep human NK cell enrichment antibody 
cocktail (0.6–0.8 mL) (StemCell Technologies, Vancouver, British Columbia, Canada) was 
added to 45 mL of buffy coat. The mixture was incubated for 25 min at room temperature (~ 
25º C). Seven (7)-8 mL of the mixture was layered onto 4 mL of Ficoll-Hypaque (1.077 
g/mL) (MP Biomedicals, Irvine, CA) and centrifuged at 1200 g for 30–50 min. NK cells 
were collected and washed twice with phosphate buffered saline (PBS) pH 7.2 and stored in 
complete media (RPMI-1640 supplemented with 10% heat-inactivated bovine calf serum 
(BCS), 2 mM L-glutamine and 50 U penicillin G with 50 μg streptomycin/ml) at 1 million 
cells/mL at 37 °C and air/CO2 , 19:1.
Preparation of monocyte- depleted PBMCs and PBMCs
Preparations of PBMCs were isolated from Leukocyte filters (PALL- RC2D) obtained from 
the Red Cross Blood Bank Facility (Nashville, TN) as described in Meyer et al., 2005. 
Leukocytes were retrieved from the filters by back-flushing them with elution medium (PBS 
containing 5 mM disodium EDTA and 2.5% [w/v] sucrose) and collecting the eluent. Eluent 
contained the leukocytes with red cell contamination. Eluent was layered onto Ficoll-
Hypaque (1.077g/mL) and centrifuged as described above. Granulocytes and red cells 
pelleted at the bottom of the tube while the PBMCs floated on the Ficoll-Hypaque. PBMCs 
were collected and washed (250 g, 10 min.) with PBS. Cells were then suspended in 
complete medium which consisted of RPMI-1640 supplemented with 10% heat-inactivated 
BCS, 2 mM L-glutamine and 50 U penicillin G with 50 μg streptomycin/mL. This 
preparation constituted PBMCs. Monocyte-depleted PBMCs (10–20% CD16+, 10–20 % 
CD56+, 70–80% CD3+, 3–5% CD19+, 2–20% CD14+) were prepared by incubating the cells 
in glass Petri dishes (150 X 15 mm) at 37 °C and air/CO2 , 19:1 for 1 h .
Chemical preparation
TBT and DBT were purchased from (Sigma-Aldrich, St. Louis, MO). TBT was a neat 
standard, dissolved initially in deionized water to give a 1 mM solution. A DBT stock 
solution was prepared by dissolving DBT in dimethylsulfoxide (DMSO). Desired 
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concentrations of either TBT or DBT were prepared by dilution of the stock into complete 
media. The final concentration of DMSO for DBT exposures did not exceed 0.01%. 
Appropriate DMSO controls were run.
Cell treatments
NK cells, monocyte-depleted PBMCs, or PBMCs (at a concentration of 1.5 million 
cells/mL) were treated with TBT with appropriate control at concentrations of 2.5–200 nM 
for 24 h, 48 h, or 6 days. Cells were treated with DBT with appropriate control at 
concentrations of 0.05–5 μM for the same lengths of incubation as used with TBT. 
Following the incubations the cells were pelleted and the supernatants were collected and 
frozen at −70°C until assay.
Cell viability
Cell viability was assessed at the beginning and end of each exposure period. Viability was 
determined using the trypan blue exclusion method. Briefly, cells were mixed with trypan 
blue and counted using a hemocytometer. The total number of cells and the total number of 
live cells were determined for both control and treated cells to determine the percent viable 
cells. Results are shown in Tables 1 and 2.
IFNγ secretion assay
IFNγ levels were assessed using the OptEIA™ enzyme-linked immunosorbent assay 
(ELISA) human IFNγ kit (BD-Pharmingen, San Diego, CA). Capture antibody diluted in 
coating buffer was applied to the wells of a 96 well flat-bottom microwell plate specifically 
designed for ELISA (Fisher, St.Louis MO). The plate was incubated overnight at 4°C. 
Following the incubation, capture antibody was removed by washing the plate three times 
with wash buffer (PBS with 0.05% Tween-20). The wells were then treated with blocking 
buffer to prevent non-specific binding and the plate was sealed and incubated at room 
temperature for 1 h. Blocking buffer was removed with three washes, and cell supernatants 
and IFNγ standards were added to the plate, which was sealed and incubated at room 
temperature for 2 h. The plate was washed five times following the incubation with samples 
and standards and detection antibody was added then incubated for 1 h at room temperature. 
Detection antibody was removed by washing 7 times and a substrate solution was added to 
each well and incubated for 30 min at room temperature. The incubation with substrate was 
ended by addition of acid and the absorbance was measured at 450 nm on a Thermo 
Labsystems Multiskan MCC/340 plate reader (Fisher Scientific).
Statistical analysis
Statistical analysis of the data was carried out utilizing ANOVA and Student's t test. Data 
were initially compared within a given experimental setup by ANOVA. A significant 
ANOVA was followed by pair wise analysis of control versus exposed data using Student’s 
t test, a p value of less than 0.05 was considered significant.
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Viability of NK cells, monocyte-depleted PBMCs, and PBMCs exposed to TBT
Table 1 shows the effects of TBT exposures (2.5–200 nM) on the viability of highly purified 
NK cells, monocyte-depleted PBMCs, and PBMCs. Exposure of NK cells to 2.5–200 nM 
TBT for 24 h had no effect on their viability as compared to the control. Exposure to these 
same concentrations for 48 h diminished viability by a small amount at the highest 
concentration of TBT (200 nM). NK cells exposed to 2.5–200 nM TBT for 6 days showed 
no change in viability as compared to controls. Like NK cells, monocyte-depleted PBMCs 
and PBMCs both showed no negative effects of a 24 h exposure to TBT at any 
concentration, but were slightly affected by the 200 nM TBT after 48 h and more 
significantly after 6 days. This indicated that there was not a generalized toxicity of the 
compound on cells due to TBT exposures.
Viability of NK cells, monocyte-depleted PBMCs, and PBMCs exposed to DBT
The effects of DBT exposures (0.05–5 μM) on the viability of highly purified NK cells, 
monocyte-depleted PBMCs, and PBMCs are shown in Table 2. NK cells exposed to 2.5 and 
5 μM DBT for 24 h showed small but significant decreases in viability as compared to the 
control. All other DBT concentrations had no effect on viability at the 24 h exposure. 48 h 
exposures to 1, 2.5 and 5 μM DBT decreased NK viability by 18%, 30%, and 32%, 
respectively. Monocyte-depleted PBMCs and PBMCs also showed significant decreases in 
viability with exposures to the highest concentrations of DBT. But as with TBT, there were 
decreases in viability only at the highest concentrations, which increased slightly with length 
of exposure.
IFNγ secretion from NK cells exposed to TBT
Table 3 shows the effects of exposing highly purified NK cells to 0, 2.5, 5, 10, 25, 50, 100 
and 200 nM TBT for 24 h, 48 h, and 6 days on IFNγ secretion from each of the donors 
tested (KB=Key Biologic buffy coat). There was very wide variation in the baseline 
secretion of IFNγ from one donor to the next at each of the time points tested. 24 h 
exposures were carried out with cells prepared from 7 individual donors and 6 of the 7 
donors showed significant decreases in IFNγ when exposed to 200 nM TBT. Cells from 5 of 
the 7 donors showed an increase in IFNγ secretion with exposure to at least one TBT 
concentration. The concentrations that caused increases varied from one donor to the next. 
For instance, the cells from donor KB114 treated with 5, 10, 25,50 and 100 nM TBT showed 
significant increases of 2.8, 2.6, 3.9, 4.3, and 1.4 fold respectively, while the cells from 
donor KB113 showed an increase of 5.5 fold only at the 25 nM exposure. When NK cells 
from 4 individual donors were exposed to TBT for 48 h there was a significant decrease in 
IFNγ, as compared to control in cells from 3 of the 4 donors at the 200 and 100 nM 
concentrations. Increases in IFNγ secretion were seen in 2 of the 4 donors, while the other 2 
donors only showed decreases (or no change) when exposed to TBT. NK cells exposed to 
TBT for 6 days all showed a significant decrease in IFNγ secretion at the 200 nM 
concentration. Cells from each of the 4 donors secreted higher levels of IFNγ when exposed 
to a minimum of one TBT concentration. The concentrations at which increases were seen 
again varied depending on the donor. Likewise the intensity of the increase varied from one 
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donor to the next as it did at 24 h and 48 h. Comparing donor KB146 to donor KB147, the 5, 
10, 25, 50, and 100 nM concentrations of TBT each caused very significant increases (4, 8.5, 
6.2, 13.8, and 4.5 fold, respectively) in secretion in cells from KB146, while only the 50 nM 
exposure to TBT caused an increase in cells from KB147 (4 fold). Figure 1A shows the 
effects at each of the time points for an individual donor (KB147).
IFNγ secretion from monocyte-depleted PBMCs exposed to TBT
The effects of exposures to TBT on secretion of IFNγ from monocyte-depleted PBMCs after 
24 h, 48 h, and 6 d from each donor (F=filter obtained from the Red Cross) are shown in 
Table 4. As with the enriched NK cell preparation, there was wide variation in the baseline 
secretion of IFNγ from monocyte-depleted PBMCs. This preparation is largely NK cells and 
T cells. When monocyte-depleted PBMCs were exposed to TBT for 24 h there were 
statistically significant increases in IFNγ secretion induced by TBT for every donor at the 25 
and 50 nM concentrations. Exposure to 200 nM TBT caused nearly complete inhibition of 
secretion in every donor. Figure 1B shows the effects of TBT exposures at each of the 
lengths of exposure for an individual donor (F142). The same pattern of increases in IFNγ 
secretion at 25 and 50 nM and a nearly complete block of secretion at the 200 nM exposure 
was seen at each of the other lengths of exposure for all donors.
IFNγ secretion from PBMCs exposed to TBT
The effects of exposing PBMCs from 4 individual donors to 0–200 nM TBT for 24 h, 48 h, 
and 6 d on the secretion of IFNγ are shown in Table 5 (F=filter obtained from the Red 
Cross). Again, there was variation among donors in the baseline secretion of IFNγ (donor 
F116 was at the high end and donor F120 at the low end). PBMCs from all 4 donors showed 
significant decreases in secretion after exposure to 200 nM TBT for 24 h. Cells from 2 of the 
4 donors (F116 and F117) were either unchanged or showed decreased secretion of IFNγ 
when exposed to TBT at any length of exposure. PBMCs from donors F119 and F120 
produced increased amount of IFNγ when exposed to certain concentrations of TBT at every 
length of exposure. For example, F120 PBMCs produced higher levels of IFNγ than control 
cells after each length of exposure, but the concentration at which the increases occurred 
varied: 5–100 nM TBT caused increased secretion after 24h (ranging as high as 2.6 fold at 
100 nM); only 50 and 100 nM TBT increased secretion after 48 h (with 100 nM causing an 
8 fold increase); after 6 d of exposure to 100 nM TBT the increase in secretion was 19 fold. 
The effects of TBT exposures on PBMCs from donor F120 at each of the time points are 
shown in Figure 1C.
IFNγ secretion from NK cells exposed to DBT
Effects of exposing highly purified NK cells to 0, 0.05, 0.1, 0.25, 0.5, 1, 2.5 and 5 μM DBT 
for 24 h, 48 h, and 6 days on IFNγ secretion from several individual donors are shown in 
Table 6. As with the TBT exposed cells there is notable variation in the baseline secretion of 
IFNγ from individual donors. NK cells prepared from 6 donors were tested for the effect of 
24 h exposures to DBT. Secretion of IFNγ by NK cells from all 6 donors was essentially 
completely blocked by exposures to 0.5, 1, 2.5, and 5 μM DBT for 24 h. However, 4 of the 6 
donors showed increased secretion with exposures to 0.1 μM DBT for 24 h. Increases were 
also seen at the 0.05 μM in 3 of the 6 donors. 48 h exposures to DBT caused essentially a 
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complete block of IFNγ secretion at the same concentrations that blocked secretion after 24 
h. However, NK cells from all donors had increased secretion of IFNγ at the lowest level of 
DBT exposure (0.05 μM). Cells that did not show any increase in IFNγ after 24 h exposures 
to DBT exhibited increased secretion after 48 h (KB130 and KB139). Following a 6 d 
exposure to 1, 2.5, and 5 μM DBT, there was decreased secretion from cells from all 3 
donors tested. Cells from KB130 and KB155 showed increased secretion in response to 6 
day exposures to several DBT concentrations (peak increases of 1.5 fold and 2.8 fold at 0.05 
μM for KB130 and KB155, respectively). Data from donor KB155 is plotted for all time 
points in Figure 1D.
IFNγ secretion from monocyte-depleted PBMCs exposed to DBT
Results of exposing monoctye-depleted PBMCs isolated from different donors to 0–5 μM 
DBT for 24 h, 48 h, and 6 days on IFNγ secretion are shown in Table 7. When cells isolated 
from 6 donors were exposed to DBT for 24 h, secretion of IFNγ was significantly decreased 
at the 0.5, 1, 2.5, and 5 μM concentrations in 5 of the 6 donors. Cells from 5 of the 6 donors 
also showed increased secretion with exposures to DBT for 24 h. The concentrations at 
which DBT caused increased secretion varied among donors. Exposures to 1, 2.5, and 5 μM 
DBT for 48 h almost completely blocked the secretion of IFNγ from PBMCs regardless of 
donor. Likewise, PBMCs from all donors had increased secretion of IFNγ at exposure to 
DBT at lower concentrations (which varied among donors). The intensity of the increase 
also varied depending on the donor. This same pattern persisted out to 6 days of exposure. 
Figure 1E shows the effects of 0–200 nM exposure for 24 h, 48 h, and 6d for cells from 
donor F142.
IFNγ secretion from PBMCs exposed to DBT
Alterations in IFNγ secretion caused by exposing PBMCs isolated from different donors to 
0–5 μM DBT for 24 h, 48 h, and 6 days are shown in Table 8. As was seen with NK cells 
and monocyte-depleted PBMCs, there is a consistent decrease in IFNγ secretion at the 
highest DBT concentrations (0.5–5 μM) after 24 h. In contrast to the less reconstituted cell 
preparations, PBMCs did not show a strong pattern of increased secretion at the lower 
concentration of DBT with a 24 h exposure. While the highest concentrations of DBT (5 and 
2.5) continued to cause decreased IFNγ secretion after 48 h and 6d, there were significant 
increases in IFNγ secretion in 4 of 6 donors after 48 h and 3 of 4 donors after 6 d. All but 
one donor (F117) showed an increase in IFNγ after at least one exposure length 
(concentration at which this occurred varied among the donors). Data for 24 h, 48 h, and 6 d 
exposure of PBMCs from donor F120 are plotted in Figure 1F.
DISCUSSION
IFNγ is an important regulator of immune responsiveness that is produced primarily by T 
and NK lymphocytes and to some extent by myeloid cells (Zaidi and Merlino, 2011, Billiau 
and Matthys, 2009; Darwich et al., 2008). It is important to determine the effects of 
environmental contaminants such as the BTs (which have been found in human blood) 
(Whalen et al., 1999; Kannan et al., 1999) on the secretion of this potent regulator. 
Compound-induced decreases in IFNγ secretion could lead to loss of appropriate Th-1 cell 
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development and macrophage stimulation, both of which are crucial in establishing an 
immune response to pathogens (Schroder et al., 2004). Alternatively, if a compound were to 
increase IFNγ levels, this could lead to out of control inflammatory response, which is 
known to be a factor in a number of diseases including cancer (Macarthur et al., 2004). In 
this study we examined the effects of both TBT and DBT on secretion of IFNγ by immune 
system cells.
The effects of TBT and DBT on IFNγ secretion were examined in three distinct cell 
preparations (highly enriched NK cells, monocyte-depleted PBMCs and PBMCs). This type 
of study is important in order to determine if increasing the complexity of the cell population 
altered the effects of exposures to the compounds. It is not possible to carry out studies of 
these compounds in humans. Thus, studies carried out in more reconstituted systems such as 
the ones examined here will more closely approximate the effects that might be seen in vivo.
When highly purified NK cells were exposed to 200 nM TBT there was a substantial 
decrease in secretion of IFNγ. This effect remained as the cell preparation became more 
complex, with both monocyte-depleted PBMCs and PBMCs having the same patterns of 
response to TBT exposures as did the highly enriched NK cells. A notable difference was 
that monocyte-depleted PBMCs (which are primarily T cells and NK cells) had a consistent 
increase at the lower TBT concentrations at more time points than were seen with either NK 
cells alone or with PBMCs. Additionally, stimulation of IFNγ secretion with TBT was less 
common in the PBMCs than in NK cells or monocyte-depleted NK cells. This suggests that 
the presence of monocytes diminished the increases in secretion seen at low TBT 
concentrations (usually in the 50 nM to 2.5 nM range) that were quite consistently seen in 
the non-monocyte containing preparation. As monocytes are not considered to be significant 
secretors of IFNγ, their presence may simply be dampening the ability to see the TBT-
induced stimulations. Alternatively, it may be that monocytes are secreting a factor(s) that 
interferes with TBT-induced secretion of IFNγ. The fact that increases are seen but not as 
consistently or intensely could be explained by either scenario. TBT-induced decreases in 
IFNγ secretion at the 200 and 100 nM TBT concentrations are quite reproducible among the 
3 different cell preparations. Thus, TBT is altering secretion of IFNγ by diminishing its 
secretion at the highest levels of exposure while stimulating secretion at concentrations of 50 
nM and below. These changes are seen with even the most reconstituted cell system studied, 
indicating that the effect has significant potential to be occurring in a physiologically 
relevant setting.
Decreases induced by the higher TBT concentrations would prevent IFNγ from carrying out 
its important role in regulating T-cell development and macrophage effector functions 
(Schroder et al. 2004). Conversely, TBT-induced increases in a pro-inflammatory cytokine 
such as IFNγ can lead to a number of diseases that are caused or exacerbated by increased 
inflammation (Macarthur et al., 2004). Secretion of IFNγ by human NK cells has been 
shown to require mitogen activated protein kinase (MAPK) activation (Girart et al., 2007). 
The effects of TBT on IFNγ secretion are occurring at levels that are found in human blood 
and because of the important role of this cytokine have significant implications for human 
health. TBT at these levels also decreases the lytic function of human NK cells (Dudimah et 
al., 2007a, Whalen et al., 2002). We have previously shown that TBT is able to activate 
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MAPKs in NK cells (Aluoch and Whalen, 2005; Aluoch et al., 2006; Aluoch et al., 2007). 
Future studies will investigate the role of MAPK activation in the TBT-induced changes in 
IFNγ secretion (both decreases and increases).
DBT caused very significant alterations of IFNγ secretion from each of the 3 types of cell 
preparations examined. In general, DBT at concentrations of 0.5–5 μM significantly 
decreased IFNγ secretion, with concentrations of 1–5 μM causing a complete block of 
secretion in nearly every donor of each type of cell preparation. In highly purified NK cells 
of donor KB155 there was a 12 fold increase in IFNγ secretion when the cells were exposed 
to 0.1μM DBT (100 nM) for 48 h, which is well below the highest levels that have been 
found in some human blood samples (300 nM) (Whalen et al., 1999; Kannan et al., 1999). In 
monocyte-depleted PBMCs, this same concentration of DBT after 48 h was able to cause a 
similar (8.5 fold) very large increase in IFNγ secretion in cells from donor F105. The peak 
increase for that donor after 48 h was at the 0.25 μM concentration and was 16.7 fold. 
PBMCs treated for 48 h at these same concentrations of DBT also had one donor (F120) that 
showed a very large stimulation of IFNγ secretion. The majority of increases seen with DBT 
were more modest than those mentioned above but range in the 2–3 fold level. Thus, in 
contrast to what was seen with TBT, the effects of DBT did not seem to be different as the 
complexity of the cell population increased. Like TBT, DBT exposures also caused very 
large decreases in IFNγ secretions at the highest concentrations and increased secretion at 
lower concentrations. The decreases of secretion cannot be accounted for simply by 
compound-induced killing of the cells, although concentrations of 1–5 μM do cause some 
cell death as length of exposure increases. Stimulation of secretion occurs at concentrations 
that have no negative impact on cell viability. Thus, indicating that the compound is in some 
manner activating IFNγ secretion and/or synthesis. As with TBT, DBT has been shown to 
decrease NK lytic function (Dudimah et al., 2007b, Whalen et al., 2002) and activate 
MAPKs (Odman-Ghazi et al., 2010) at some of these same concentrations that are affecting 
IFNγ secretion.
It is clear from this study that there is significant variability among donors both in their 
response to compound exposures as well as the baseline levels of IFNγ secretion. It is not 
clear what causes the variation in baseline IFNγ secretion, but clearly individuals vary quite 
widely in their baseline secretion and in the exact concentrations and lengths of exposure to 
a compound that elicit a stimulatory effect on IFNγ secretion. Interestingly, while there is 
some variation in baseline lytic function of highly purified NK cells among different donors 
it is less than what is seen with IFNγ secretion. Additionally, the effects of TBT and DBT 
exposures on NK lytic function were also not as variable (Dudimah et al. 2007a, 2007b). 
The monocyte-depleted PBMCs and PBMCs also show some variability in lytic function 
from donor to donor and are far less susceptible to exposure to BTs and other contaminants 
than the highly purified NK cells (Whalen et al., 1999; Whalen et al., 2003; Reed et al., 
2004; Taylor et al., 2005). While the lytic function of highly purified NK cells is blocked by 
exposures as low as 25 nM after 6 days of exposure only the highest concentrations of TBT 
(200 nM) caused decreases in lytic function of the monocyte-depleted PBMCs and PBMCs 
at any length of incubation including 6 days (Whalen et al., 1999; Dudimah et al., 2007a). 
Again, the response of lytic function to compound exposures was far less variable in any of 
the cell preparations than is the response of IFNγ secretion. Additionally, the capacity of 
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both BTs to stimulate secretion of IFNγ was seen at lower concentrations of BT exposure 
where no effects on lytic function were seen (especially in the more reconstituted cell 
systems).
A stimulatory effect on secretion is common to nearly every donor with both TBT and DBT 
exposures. This is true from the least to the most reconstituted cell preparations. A previous 
study examined effects of both TBT and DBT on secretion of TNFα from human white 
blood cells. That study showed that TBT caused decreased secretion of TNFα in NK cells. 
There was no TBT-induced stimulation of secretion at any concentration in purified NK 
cells. However TBT (at lower concentrations) did stimulate secretion of TNFα in a cell 
preparation that contained both T and NK cells (monocyte-depleted PBMCs). DBT, at 
higher concentrations, decreased TNFα secretion and increased secretion at lower 
concentrations in both NK cell and the monocyte-depleted cell preparations (Hurt et al., 
2013). This is in contrast to the effects of these compounds on IFNγ, where the composition 
of the cell preparation did not influence the effectiveness of DBT and had only a moderating 
influence with TBT.
In summary, the current study shows that secretion of IFNγ in three distinct immune cell 
preparations is altered by BT exposures. Exposures to both TBT and DBT result in 
significant decreases in IFNγ secretion at the highest exposure levels. Each compound is 
able to stimulate secretion of IFNγ from each of the three cell preparations, but the 
magnitude of the increase as well as the concentration and length of exposure at which the 
stimulation occurred, varied from one donor to the next.
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Effects of 24 h, 48 h and 6 day exposures to TBT and DBT on IFNγ secretion from highly 
purified human NK cells, monocyte-depleted PBMCs, and PBMCs in an individual donor. 
A) NK cells exposed to 0–200 nM TBT (donor KB147). B) Monocyte-depleted PBMCs 
exposed to 0–200 nM TBT (donor F142). C) PBMCs exposed to 0–200 nM TBT (donor 
F120). D) NK cells exposed to 0–5 μM DBT (donor KB155). E) Monocyte-depleted PBMCs 
exposed to 0–5 μM DBT (donor F142). F) PBMCs exposed to 0–5 μM DBT (donor F120). 
The data point for a 48 h exposure of NK cells to 2.5 nM TBT (177±120 pg/mL) was 
omitted in (A) as it was not significant and made it difficult to see the effects at other 
concentrations.
Lawrence et al. Page 13

























Lawrence et al. Page 14
Table 1
Percent viability of NK cells, Monocyte-depleted PBMCs and PBMCs exposed to TBT for 24 h, 48 h and 6 
days.
Percent Viable Cells
24 h exposure [TBT] nM NK Monocyte-depleted PBMCs PBMCs
0 96±3 97±3 96±3
2.5 96±3 98±1 98±2
5 97±2 99±1 97±3
10 97±2 98±2 96±2
25 98±1 98±2 98±2
50 96±2 96±6 97±2
100 96±1 98±2 97±2
200 92±6 92±4 95±2
48 h exposure 0 96±1 95±3 96±3
2.5 96±2 98±1 94±5
5 97±1 99±1 96±3
10 97±1 97±1 97±7
25 95±3 96±1 95±4
50 96±2 94±3 96±4
100 94±3 89±9 98±1
200 82±5* 77±5* 84±4*
6 day exposure 0 78±4 84±11 93±2
2.5 78±4 87±4 92±1
5 81±3 88±10 95±2
10 80±7 90±10 94±2
25 80±5 85±13 94±2
50 74±8 74±17 92±6
100 72±6 64±12 86±8
200 66±11 54±13* 74±5*
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant decrease in viability compared to control cells, p<0.05
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Table 2
Percent viability of NK cells, Monocyte-depleted PBMCs and PBMCs exposed to DBT for 24 h, 48 h and 6 
days.
Percent Viable Cells
24 h exposure [DBT] μM NK Monocyte-depleted PBMCs PBMCs
0 95±2 96±2 95±3
0.05 96±3 97±2 98±2
0.1 95±4 98±3 97±2
0.25 94±6 96±2 96±2
0.5 94±2 97±3 95±4
1 87±9 95±4 93±7
2.5 88±6* 84±9* 90±14
5 81±10* 83±6* 87±7*
48 h exposure 0 93±4 96±2 96±2
0.05 96±4 98±2 96±1
0.1 95±3 99±1 96±3
0.25 93±2 97±1 96±4
0.5 89±2 94±6 95±7
1 75±7* 86±3* 84±13
2.5 63±3* 71±16* 76±11*
5 61±11* 69±9* 73±4*
6 day exposure 0 73±15 87±9 90±7
0.05 74±7 88±7 89±6
0.1 77±8 89±8 91±8
0.25 75±8 79±11 85±14
0.5 72±2 67±13* 80±17
1 67±6 57±10* 73±11*
2.5 57±10 53±14* 69±10*
5 57±14 64±5* 67±1*
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant decrease in viability compared to control cells, p<0.05
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